These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16487839)

  • 21. Natriuretic peptides and heart failure.
    McLachlan CS; Yu H; Mossop P
    CMAJ; 2007 Feb; 176(5):659. PubMed ID: 17325337
    [No Abstract]   [Full Text] [Related]  

  • 22. B-type natriuretic peptide and cardiovascular disease.
    da Silva LB; Ferreira CA; Blacher C; Leáes P; Haddad H
    Arq Bras Cardiol; 2003 Nov; 81(5):529-39. PubMed ID: 14666275
    [No Abstract]   [Full Text] [Related]  

  • 23. B-type natriuretic peptide in heart failure.
    Foote RS; Pearlman JD
    N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12479193
    [No Abstract]   [Full Text] [Related]  

  • 24. B-type natriuretic peptide in the emergency department: a valuable diagnostic aid.
    Maisel AS; Doyle J
    Acad Emerg Med; 2005 Jun; 12(6):572-3; author reply 573-4. PubMed ID: 15930411
    [No Abstract]   [Full Text] [Related]  

  • 25. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide in the evaluation of acute dyspnea.
    Martinez-Selles M
    N Engl J Med; 2004 Jun; 350(23):2416-7; author reply 2416-7. PubMed ID: 15175447
    [No Abstract]   [Full Text] [Related]  

  • 27. B-type natriuretic peptide serum levels in acute heart failure.
    Filippatos GS; Anker SD; Kardaras F
    Eur Heart J; 2004 Jun; 25(12):1085; author reply 1085-6. PubMed ID: 15191781
    [No Abstract]   [Full Text] [Related]  

  • 28. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular reconstruction: the aim and the reality after twenty years.
    Dor V
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):17-20. PubMed ID: 15224016
    [No Abstract]   [Full Text] [Related]  

  • 32. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 33. Brain natriuretic peptide in heart failure.
    Aronow WS
    J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
    [No Abstract]   [Full Text] [Related]  

  • 34. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Nishikimi T; Matsuoka H
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232833
    [No Abstract]   [Full Text] [Related]  

  • 35. B-type natriuretic peptide as a marker of heart failure: Not so specific after all?
    Marshall W; Orlando R
    Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197
    [No Abstract]   [Full Text] [Related]  

  • 36. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Januzzi JL; Maisel AS
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15226236
    [No Abstract]   [Full Text] [Related]  

  • 37. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum biomarkers for heart failure.
    Jarolim P
    Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
    Katz JN; Drazner MH
    Am Heart J; 2005 Jul; 150(1):1-3. PubMed ID: 16084142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.